No abstract available
MeSH terms
-
Cicatrix / prevention & control*
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Dermatologic Agents / pharmacology
-
Dermatologic Agents / therapeutic use
-
Humans
-
Research Design
-
Transforming Growth Factor beta3 / pharmacology
-
Transforming Growth Factor beta3 / physiology
-
Transforming Growth Factor beta3 / therapeutic use*
-
Treatment Outcome
-
Wound Healing / drug effects*
-
Wound Healing / physiology
Substances
-
Dermatologic Agents
-
Transforming Growth Factor beta3